Shots: Zydus to advance the new IO therapies through formal clinical studies and receives exclusive rights to develop and commercialize the therapy in India, Brazil, Mexico and other emerging markets […]readmore
Tags : Xoma
Shots: Aronora to receive $6M upfront & $3M upon fulfillment of certain conditions. Xoma to get rights to royalties and 10% of milestone payments associated with five hematology assets from […]readmore